Indogulf Cropsciences IPO
Live Updates, GMP, Subscription Data, and Financial Details
IPO Overview
Listed
Dates
Jun 26 to Jun 30 2025
Price Band
₹111
Current GMP
₹111(0.00%)
Subscription
27.17 times
IPO Details
| IPO Date | June 26, 2025 to June 30, 2025 |
| Listing Date | July 3, 2025 |
| Face Value | ₹10 per share |
| Issue Price | ₹111 per share |
| Lot Size | 135 Shares |
| Sale Type | Fresh Capital-cum-Offer for Sale |
| Total Issue Size | 1,80,18,017 shares (aggregating up to ₹200.00 Cr) |
| Fresh Issue | 1,44,14,414 shares (aggregating up to ₹160.00 Cr) |
| Offer for Sale | 36,03,603 shares of ₹10 (aggregating up to ₹40.00 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 4,87,87,456 shares |
| Share Holding Post Issue | 6,32,01,870 shares |
IPO Date
June 26, 2025 to June 30, 2025
Listing Date
July 3, 2025
Face Value
₹10 per share
Issue Price
₹111 per share
Lot Size
135 Shares
Sale Type
Fresh Capital-cum-Offer for Sale
Total Issue Size
1,80,18,017 shares (aggregating up to ₹200.00 Cr)
Fresh Issue
1,44,14,414 shares (aggregating up to ₹160.00 Cr)
Offer for Sale
36,03,603 shares of ₹10 (aggregating up to ₹40.00 Cr)
Issue Type
Bookbuilding IPO
Listing At
BSE, NSE
Share Holding Pre Issue
4,87,87,456 shares
Share Holding Post Issue
6,32,01,870 shares
IPO Subscription Details
| Anchor Investors | 1 |
| Qualified Institutions | 31.73 |
| Non-Institutional Buyers | 49.06 |
| bNII (bids above ₹10L) | 52.13 |
| sNII (bids below ₹10L) | 42.91 |
| Retail Investors | 14.97 |
| Total ** | 27.17 |
Anchor Investors
1
Qualified Institutions
31.73
Non-Institutional Buyers
49.06
bNII (bids above ₹10L)
52.13
sNII (bids below ₹10L)
42.91
Retail Investors
14.97
Total **
27.17
Day Wise Sub
| Day | QIB | NII | NII (> ₹10L) | NII (< ₹10L) | Retail | Total |
|---|---|---|---|---|---|---|
| Day 1 Jun 26, 2025 | 0.05 | 0.27 | 0.13 | 0.54 | 0.71 | 0.42 |
| Day 2 Jun 27, 2025 | 0.05 | 0.86 | 0.55 | 1.48 | 1.58 | 0.98 |
| Day 3 Jun 30, 2025 | 31.73 | 49.06 | 52.13 | 42.91 | 14.97 | 27.17 |
DayDay 1
Jun 26, 2025
QIB0.05
NII0.27
NII (> ₹10L)0.13
NII (< ₹10L)0.54
Retail0.71
Total0.42
DayDay 2
Jun 27, 2025
QIB0.05
NII0.86
NII (> ₹10L)0.55
NII (< ₹10L)1.48
Retail1.58
Total0.98
DayDay 3
Jun 30, 2025
QIB31.73
NII49.06
NII (> ₹10L)52.13
NII (< ₹10L)42.91
Retail14.97
Total27.17
Day Wise GMP
| Date | Price | GMP | Estimate List Price |
|---|---|---|---|
| 03-07-2025 | 111.00 | 18(16.22%) | 129 |
| 02-07-2025 | 111.00 | 18(16.22%) | 129 |
| 01-07-2025 | 111.00 | 12(10.81%) | 123 |
| 30-06-2025 | 111.00 | 12(10.81%) | 123 |
| 29-06-2025 | 111.00 | 17(15.32%) | 128 |
| 28-06-2025 | 111.00 | 17(15.32%) | 128 |
| 27-06-2025 | 111.00 | 9(8.11%) | 120 |
| 26-06-2025 | 111.00 | 9(8.11%) | 120 |
| 25-06-2025 | 111.00 | 11(9.91%) | 122 |
| 24-06-2025 | 111.00 | 11(9.91%) | 122 |
| 23-06-2025 | 111.00 | 11(9.91%) | 122 |
| 22-06-2025 | 0(%) | (%) |
Date03-07-2025
Price111.00
GMP18(16.22%)
Estimate List Price129
Date02-07-2025
Price111.00
GMP18(16.22%)
Estimate List Price129
Date01-07-2025
Price111.00
GMP12(10.81%)
Estimate List Price123
Date30-06-2025
Price111.00
GMP12(10.81%)
Estimate List Price123
Date29-06-2025
Price111.00
GMP17(15.32%)
Estimate List Price128
Date28-06-2025
Price111.00
GMP17(15.32%)
Estimate List Price128
Date27-06-2025
Price111.00
GMP9(8.11%)
Estimate List Price120
Date26-06-2025
Price111.00
GMP9(8.11%)
Estimate List Price120
Date25-06-2025
Price111.00
GMP11(9.91%)
Estimate List Price122
Date24-06-2025
Price111.00
GMP11(9.91%)
Estimate List Price122
Date23-06-2025
Price111.00
GMP11(9.91%)
Estimate List Price122
Date22-06-2025
Price
GMP0(%)
Estimate List Price(%)
IPO Important Dates
| IPO Open Date | Thu, Jun 26, 2025 |
| IPO Close Date | Mon, Jun 30, 2025 |
| Tentative Allotment | Tue, Jul 1, 2025 |
| Initiation of Refunds | Wed, Jul 2, 2025 |
| Credit of Shares to Demat | Wed, Jul 2, 2025 |
| Tentative Listing Date | Thu, Jul 3, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on June 30, 2025 |
IPO Open Date
Thu, Jun 26, 2025
IPO Close Date
Mon, Jun 30, 2025
Tentative Allotment
Tue, Jul 1, 2025
Initiation of Refunds
Wed, Jul 2, 2025
Credit of Shares to Demat
Wed, Jul 2, 2025
Tentative Listing Date
Thu, Jul 3, 2025
Cut-off time for UPI mandate confirmation
5 PM on June 30, 2025
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 135 | ₹14,985 |
| Retail (Max) | 13 | 1755 | ₹1,94,805 |
| S-HNI (Min) | 14 | 1,890 | ₹2,09,790 |
| S-HNI (Max) | 66 | 8,910 | ₹9,89,010 |
| B-HNI (Min) | 67 | 9,045 | ₹10,03,995 |
ApplicationRetail (Min)
Lots1
Shares135
Amount₹14,985
ApplicationRetail (Max)
Lots13
Shares1755
Amount₹1,94,805
ApplicationS-HNI (Min)
Lots14
Shares1,890
Amount₹2,09,790
ApplicationS-HNI (Max)
Lots66
Shares8,910
Amount₹9,89,010
ApplicationB-HNI (Min)
Lots67
Shares9,045
Amount₹10,03,995
Financial Information
| Period Ended | 31 Dec 2024 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Period Ended | 31 Dec 2024 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 597.81 | 542.25 | 517.51 |
| Revenue | 466.31 | 555.79 | 552.19 |
| Profit After Tax | 21.68 | 28.23 | 22.42 |
| EBITDA | 44.78 | 55.74 | 49.04 |
| Net Worth | 265.43 | 231.65 | 203.25 |
| Reserves and Surplus | 216.64 | 208.01 | 179.60 |
| Total Borrowing | 206.30 | 154.56 | 189.22 |
Period EndedPeriod Ended
31 Dec 202431 Dec 2024
31 Mar 202431 Mar 2024
31 Mar 202331 Mar 2023
Period EndedAssets
31 Dec 2024597.81
31 Mar 2024542.25
31 Mar 2023517.51
Period EndedRevenue
31 Dec 2024466.31
31 Mar 2024555.79
31 Mar 2023552.19
Period EndedProfit After Tax
31 Dec 202421.68
31 Mar 202428.23
31 Mar 202322.42
Period EndedEBITDA
31 Dec 202444.78
31 Mar 202455.74
31 Mar 202349.04
Period EndedNet Worth
31 Dec 2024265.43
31 Mar 2024231.65
31 Mar 2023203.25
Period EndedReserves and Surplus
31 Dec 2024216.64
31 Mar 2024208.01
31 Mar 2023179.60
Period EndedTotal Borrowing
31 Dec 2024206.30
31 Mar 2024154.56
31 Mar 2023189.22
IPO Reservation
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| QIB Shares Offered | 90,09,009 (50.00%) | NA |
| − Anchor Investor Shares Offered | 52,43,242 (29.10%) | NA |
| − QIB (Ex. Anchor) Shares Offered | 37,65,767 (20.90%) | NA |
| NII (HNI) Shares Offered | 27,02,703 (15.00%) | NA |
| − bNII > ₹10L | 18,01,802 (10.00%) | 953 |
| − sNII < ₹10L | 9,00,901 (5.00%) | 476 |
| Retail Shares Offered | 63,06,306 (35.00%) | 46,713 |
| Total Shares Offered | 1,80,18,018 (100.00%) |
Investor CategoryQIB Shares Offered
Shares Offered90,09,009 (50.00%)
Maximum AllotteesNA
Investor Category− Anchor Investor Shares Offered
Shares Offered52,43,242 (29.10%)
Maximum AllotteesNA
Investor Category− QIB (Ex. Anchor) Shares Offered
Shares Offered37,65,767 (20.90%)
Maximum AllotteesNA
Investor CategoryNII (HNI) Shares Offered
Shares Offered27,02,703 (15.00%)
Maximum AllotteesNA
Investor Category− bNII > ₹10L
Shares Offered18,01,802 (10.00%)
Maximum Allottees953
Investor Category− sNII < ₹10L
Shares Offered9,00,901 (5.00%)
Maximum Allottees476
Investor CategoryRetail Shares Offered
Shares Offered63,06,306 (35.00%)
Maximum Allottees46,713
Investor CategoryTotal Shares Offered
Shares Offered1,80,18,018 (100.00%)
Maximum Allottees
Information about company
Incorporated in 1993, Indogulf Cropsciences Limited is engaged in manufacturing crop protection products, plant nutrients, and biologicals in India.
The company manufactured Spiromesifen technical with 96.5% purity in 2019 and is one of the first indigenous manufacturers of Pyrazosulfuron Ethyl technical with 97% purity in India.
The company operates four manufacturing facilities in Samba (Jammu & Kashmir) and Nathupur (Haryana), covering approximately twenty acres, including two sites in Nathupur and one in Barwasni, Haryana.
The company has a sales network across 22 states and 3 Union Territories in India, with 169 business partners, 5,772 distributors, and 129 partners in 34 countries worldwide.
The company’s flexible, multi-purpose facilities allow diverse product manufacturing, adapting to customer needs. Its competitive advantage is strengthened by high regulatory barriers in the agrochemical industry, including costs and complex approvals.
Product Portfolio:
Plant Nutrients: The company manufactures specialty fertilizers, bio-simulants, and performance products, including straight fertilizers and soil health products, to enhance soil fertility, stimulate root growth, and improve crop yields.
Crop Protection Products: The company manufactures crop protection products, including insecticides, fungicides, herbicides, and bio-stimulants, designed to safeguard crops from pests, diseases, and weeds, ensuring healthy growth and productivity.
Biologicals: The company offers biological products, including bio-stimulants and bio-fertilizers, to improve crop growth, nutrient uptake, stress tolerance, and overall sustainability, with products like Biogold, Indo Breeza, and Indo Mychoriza.
As of August 31, 2024, the company had 640 permanent employees.
Competitive Strengths:
Diversified product portfolio and specialized products across all three verticals.
Established distribution network in India and abroad.
Backward integrated manufacturing infrastructure.
Strong R&D and product development capabilities.
Experienced Promoters and a strong management team.
Objectives of IPO
The Company Indogulf Cropsciences IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
S.No.
Objects of the Issue
Expected Amount (₹ in crores)
1
Funding working capital requirements of our Company
65.00
2
Repayment/ prepayment, in full or in part, of certain outstanding borrowings availed by our Company
34.12
3
Capital expenditure of our Company for setting up an in-house dry flowable (DF) plant at Barwasni, District Sonipat, Haryana
14.00
4
General corporate purposes
Disclaimer
All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application.
No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever
Please read all Tearms and conditions , and agree to use the App